Create your Personal Health Record and unlock support built around you

  • Treatments and trials you qualify for
  • Education for your stage of care
  • Financial support for your medications
  • Solutions to your side effects
Video

BETA - What is HealthTree's Black Myeloma Health Program?

Posted by
HealthTree Logo HealthTree
• August 20, 2024

Description

Learn about HealthTree's Black Myeloma Health Program in this HealthTree University lesson.

On this video

Healthtree contact Valarie Traynham

Valarie Traynham

Transcript

What is Health Tree's Black Myeloma Health Program? The Black Myeloma Health Program is an initiative launched by the Health Tree Foundation to address racial disparities in the diagnosis, treatment, and outcome of multiple myeloma amongst Black patients. Despite advances in myeloma research and treatment, Black individuals are disproportionately affected by the disease and often experience poorer outcomes compared to other racial groups. The key objectives of the Black Myeloma Health Program include awareness and education. This program aims to raise awareness about multiple myeloma within the Black community, providing educational resources, outreach initiatives, and culturally sensitive materials to empower individuals to manage symptoms of the disease and seek timely medical care. Advocacy and Equity. The program advocates for equity in access to quality health care and treatment options for Black myeloma patients, addressing systemic barriers and disparities contributing to unequal outcomes. By amplifying the voices of Black patients, the program seeks to improve health equity and reduce disparities in myeloma care. Another component of the program is community engagement. The program fosters partnerships with community organizations, health care providers, and advocacy groups to engage and mobilize the Black community. Through outreach events, support groups, and collaborative initiatives, the program seeks to build trust, foster dialogue, and empower individuals to take control of their health. The research and innovation component of the program supports research initiatives focused on understanding the unique biological characteristics and treatment responses of myeloma in Black patients with the goal of developing tailored therapies and improving outcomes. The program aims to generate evidence-based insights and advance personalized approaches to myeloma care by promoting diversity and inclusion in clinical trials and research studies.

Related Content